THERAVANCE COLLABORATION AGREEMENT AMENDMENTTheravance Collaboration Agreement • March 6th, 2014 • Theravance Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 6th, 2014 Company Industry JurisdictionThis Theravance Collaboration Agreement Amendment (the “Amendment”) is entered into on March 3, 2014 between Theravance, Inc., a Delaware corporation (“Theravance”), and Glaxo Group Limited, a private company limited by shares registered under the laws of England and Wales (“GSK”), and amends and supplements the Collaboration Agreement entered into as of November 14, 2002, as amended on April 11, 2006 (the “Collaboration Agreement”).